Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum: Three-Month follow-up of heterologous vs. homologous third SARS-CoV-2 vaccination in kidney transplant recipients: Secondary analysis of a randomized controlled trial.
Heinzel A, Schrezenmeier E, Regele F, Hu K, Raab L, Eder M, Aigner C, Jabbour R, Aschauer C, Stefanski AL, Dörner T, Budde K, Reindl-Schwaighofer R, Oberbauer R. Heinzel A, et al. Among authors: jabbour r. Front Med (Lausanne). 2022 Oct 10;9:1048395. doi: 10.3389/fmed.2022.1048395. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36300193 Free PMC article.
Three-Month Follow-Up of Heterologous vs. Homologous Third SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Secondary Analysis of a Randomized Controlled Trial.
Heinzel A, Schrezenmeier E, Regele F, Hu K, Raab L, Eder M, Aigner C, Jabbour R, Aschauer C, Stefanski AL, Dörner T, Budde K, Reindl-Schwaighofer R, Oberbauer R. Heinzel A, et al. Among authors: jabbour r. Front Med (Lausanne). 2022 Jul 22;9:936126. doi: 10.3389/fmed.2022.936126. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35935786 Free PMC article.
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients: A Randomized Clinical Trial.
Reindl-Schwaighofer R, Heinzel A, Mayrdorfer M, Jabbour R, Hofbauer TM, Merrelaar A, Eder M, Regele F, Doberer K, Spechtl P, Aschauer C, Koblischke M, Paschen C, Eskandary F, Hu K, Öhler B, Bhandal A, Kleibenböck S, Jagoditsch RI, Reiskopf B, Heger F, Bond G, Böhmig GA, Strassl R, Weseslindtner L, Indra A, Aberle JH, Binder M, Oberbauer R. Reindl-Schwaighofer R, et al. Among authors: jabbour r. JAMA Intern Med. 2022 Feb 1;182(2):165-171. doi: 10.1001/jamainternmed.2021.7372. JAMA Intern Med. 2022. PMID: 34928302 Free PMC article. Clinical Trial.
Advancements in ambulatory care pharmacy practice in Saudi Arabia: A comprehensive review of innovations and best practices at Johns Hopkins Aramco Healthcare.
Ali Thorakkattil S, Madathil H, Abideen Parakkal S, Ikram Arain S, Hamad AlDobayan Z, Abbas Abu Shoumi F, Jabbour RS, Mansour Fallatah A, Mohammed Ageeli M, Humaidi AlHarbi S. Ali Thorakkattil S, et al. Among authors: jabbour rs. Saudi Pharm J. 2024 Oct;32(10):102170. doi: 10.1016/j.jsps.2024.102170. Epub 2024 Sep 6. Saudi Pharm J. 2024. PMID: 39308955 Free PMC article.
Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
Simader FA, Rajkumar CA, Foley MJ, Ahmed-Jushuf F, Chotai S, Bual N, Khokhar A, Gohar A, Lampadakis I, Ganesananthan S, Pathimagaraj RH, Nowbar A, Davies JR, Keeble TR, O'Kane PD, Haworth P, Routledge H, Kotecha T, Spratt JC, Williams R, Nijjer SS, Sen S, Curzen N, Sinha M, Howard JP, Cole G, Harrell FE Jr, Francis DP, Shun-Shin MJ, Al-Lamee RK; ORBITA-2 Investigators. Simader FA, et al. J Am Coll Cardiol. 2024 Jul 2;84(1):13-24. doi: 10.1016/j.jacc.2024.04.016. Epub 2024 May 15. J Am Coll Cardiol. 2024. PMID: 38759906 Clinical Trial.
222 results